| Literature DB >> 31429752 |
Dominika Mravčáková1, Zora Váradyová1, Anna Kopčáková1, Klaudia Čobanová1, Ľubomíra Grešáková1, Svetlana Kišidayová1, Michal Babják2, Michaela Urda Dolinská2, Emília Dvorožňáková2, Alžbeta Königová2, Jaroslav Vadlejch3, Adam Cieslak4, Sylwester Ślusarczyk5, Marián Várady6.
Abstract
BACKGROUND: Parallel in vitro and in vivo experiments were designed to evaluate promising chemotherapeutic alternatives for controlling haemonchosis in ruminants. In vitro anthelmintic activities (egg hatch test - EHT; larval development test - LDT) of aqueous and methanolic herbal extracts Mix1 and Mix2 were investigated. The in vivo effects of dietary supplementation with Mix1 and Mix2 on the parasitological status, inflammatory response, antioxidant parameters and microbial community of the lambs infected experimentally with Haemonchus contortus were investigated. Lambs were divided into four groups for the in vivo study: uninfected control lambs (C), infected lambs (I), infected lambs supplemented with Mix1 (I + Mix1) and infected lambs supplemented with Mix2 (I + Mix2). The experimental period was 70 days.Entities:
Keywords: 16S rRNA gene; Haemonchus contortus antigen; Phytochemicals; Total antioxidant capacity; UHRMS
Mesh:
Substances:
Year: 2019 PMID: 31429752 PMCID: PMC6700814 DOI: 10.1186/s12917-019-2050-2
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Compositions of the herbal mixtures
| Mix1 | Mix2 | ||||||
| Species | Family | Part used | % in Mix1 | Species | Family | Part used | % in Mix2 |
| Asteraceae | Stem | 1.0 | Asteraceae | Stem | 1.0 | ||
| Asteraceae | Flower | 13.4 | Asteraceae | Stem | 12.4 | ||
| Apiaceae | Seed | 5.0 | Asteraceae | Flower | 12.4 | ||
| Papaveraceae | Stem | 13.4 | Asteraceae | Flower | 12.4 | ||
| Lamiaceae | Stem | 13.4 | Asteraceae | Stem | 12.4 | ||
| Malvaceae | Flower | 13.4 | Papaveraceae | Flower | 12.4 | ||
| Lamiaceae | Stem | 13.4 | Hypericaceae | Stem | 12.4 | ||
| Plantaginaceae | Leaf | 13.4 | Malvaceae | Stem | 12.4 | ||
| Asteraceae | Stem | 13.4 | Urticaceae | Stem | 12.4 | ||
Medicinal herbs (AGROKARPATY, Plavnica, Slovak Republic and BYLINY Mikeš s.r.o., Číčenice, Czech Republic)
Fermentation parameters of the dietary substrates after 24 h of in vitro incubation
| Parameter | Rumen fluid inoculum | Fresh fecal inoculum | ||||||
| Mix1 | Mix2 | MH | Concentrate | Mix1 | Mix2 | MH | Concentrate | |
| pH | 6.86 | 7.04 | 7.16 | 6.92 | 7.28 | 7.32 | 7.41 | 7.13 |
| NH3-N (mg/L) | 130 | 147 | 122 | 126 | 158 | 218 | 167 | 127 |
| Total gas (mL/g DM) | 180 | 178 | 120 | 222 | 91 | 90 | 61 | 140 |
| CH4 (mmol) | 6.99 | 6.68 | 7.90 | 7.62 | 6.49 | 6.21 | 7.05 | 7.06 |
| Total SCFA (mmol/L) | 48.3 | 47.8 | 42.4 | 53.4 | 46.8 | 47.2 | 43.1 | 49.3 |
| Acetate (mol%) | 60.0 | 60.3 | 69.1 | 63.4 | 66.3 | 65.9 | 66.1 | 67.2 |
| Propionate (mol%) | 16.4 | 16.4 | 17.2 | 19.1 | 20.1 | 20.9 | 20.2 | 23.7 |
| Butyrate (mol%) | 10.9 | 10.3 | 10.4 | 13.1 | 3.14 | 2.82 | 2.50 | 8.82 |
| Total ciliate protozoa (103/mL) | 94 | 99 | 114 | 160 | – | – | – | – |
| 91 | 96 | 111 | 155 | – | – | – | – | |
| 2.96 | 3.19 | 3.17 | 5.39 | – | – | – | – | |
Mix1 herbal mixture 1, Mix2 herbal mixture 2, Concentrate commercial concentrate composed of barley, soybean meal, wheat bran, bicarbonate and mineral–vitamin premix, MH meadow hay
Contents of the main bioactive compounds identified in the Mix1 analyzed in negative-ionization mode
| No. | Compound | RT (min) | UV | Formula | MS2 main ion | MS2 fragments | mg/g DM | |
| 1 | 4-O-Caffeoylquinic acid | 3.8 | 215/325 | 353.0880 | C16H18O9 | 191.0553 | 0.71 | |
| 2 | 3-O-Caffeoylquinic acid | 5.2 | 215/325 | 353.0880 | C16H18O9 | 191.0556 | 179/161/135 | 11.3 |
| 3 | 5-O-Caffeoylquinic acid | 5.5 | 215/325 | 353.0880 | C16H18O9 | 191.0557 | 0.73 | |
| 4 | Caffeic acid | 6.9 | 215/324 | 179.0339 | C9H8O4 | 135.0435 | 0.81 | |
| 5 | 1-O-Feruloylglucose | 8.0 | 215/324 | 355.1041 | C16H20O9 | 193.0498 | 149/0589/134 | 0.38 |
| 6 | 3-O-p-Coumaroylquinic acid | 8.7 | 215/325 | 337.0933 | C16H18O8 | 191.0187 | 173 | 0.65 |
| 7 | 4-O-p-Coumaroylquinic acid | 9.5 | 215/325 | 337.0933 | C16H18O8 | 191.0187 | 173 | 3.45 |
| 8 | Caffeoylmalic acid | 9.7 | 313/000 | 295.0455 | C13H12O8 | 179.0336 | 133/207 | 1.42 |
| 9 | 4-Caffeoylshikimic acid | 11.1 | 215/325 | 335.0768 | C16H16O8 | 179.0334 | 161/191/135 | 6.40 |
| 10 | Glucodistylin | 11.5 | 218/295 | 465.1024 | C21H22O12 | 285.0405 | 303/177 | 4.90 |
| 11 | Myricetin 3-O-galactosid | 12.2 | 271/345 | 479.0828 | C21H20O13 | 317.0297 | 20.2 | |
| 12 | Quercetin O-Pen-Hex | 12.3 | 252/351 | 595.1298 | C26H28O16 | 300.0273 | 2.63 | |
| 13 | Quercetin O-Hex-O-Dhex | 12.4 | 252/351 | 609.1442 | C27H30O16 | 447.1131 | 152/429/161/179 | 0.96 |
| 14 | Luteolin O-diglucuronide | 12.5 | 255/340 | 637.1029 | C27H26O18 | 461.0707 | 285/04 | 0.26 |
| 15 | Rutin | 13.5 | 255/342 | 609.1451 | C27H30O16 | 300.0275 | 2.96 | |
| 16 | Acetoside (verbascoside) | 13.9 | 218/291/331 | 623.1972 | C29H36O15 | 461.1657 | 161/153/179/135 | 0.63 |
| 17 | Quercetin O-Hex | 15.0 | 257/351 | 463.0874 | C21H20O12 | 300.0273 | 0.02 | |
| 18 | Quercetagetin 3′-methyl-ether 7-glucoside | 15.1 | 252/351 | 493.0977 | C22H22O13 | 447.0928 | 331/285 | 0.30 |
| 19 | 3,5-Dicaffeoylquinic acid | 15.2 | 215/325 | 515.1195 | C25H24O12 | 353.0877 | 173/179/335/191/161 | 0.42 |
| 20 | Quercetin O-Pen | 15.3 | 252/351 | 433.0776 | C20H18O11 | 300.0277 | 271/255/151 | 1.41 |
| 21 | 1,5-Dicaffeoylquinic acid | 15.4 | 215/325 | 515.1194 | C25H24O12 | 353.0885 | 191/179/135 | 15.4 |
| 22 | Qquercitrin | 15.4 | 256/348 | 447.0904 | C21H20O11 | 300.0276 | 1.88 | |
| 23 | Apigenin O-Hex | 15.5 | 267/341 | 431.0983 | C21H20O10 | 268.0371 | 0.33 | |
| 24 | Isorhamnetin O-Dhex-Dhex | 15.7 | 267/349 | 607.1666 | C28H32O15 | 299.058 | 284 | 0.15 |
| 25 | Quercetin O-(Hex-Ac) | 15.9 | 267/340 | 505.0969 | C23H22O13 | 300.0727 | 0.24 | |
| 26 | Rosmarinic acid | 16.1 | 218/287/329 | 359.0781 | C18H16O8 | 161.023 | 197/179 | 5.95 |
| 27 | Kaempferol O-glucuronide | 27.2 | 461.0727 | C21H18O12 | 285.0406 | 137 | 0.23 | |
| 28 | 3-Dihydrocaffeoyl-4-caffeoyl quinic acid | 16.4 | 215,325 | 517.1354 | C25H26O12 | 355.1239 | 161/179/323 | 9.72 |
| 29 | Kaempferol O-(Hex-Ac) | 16.8 | 489.1036 | C23H22O12 | 284.0325 | 255/227/327 | 0.72 | |
| 30 | Myricitrin glucuronide | 18.5 | 519.1143 | C24H24O13 | 314.0435 | 269/243/357 | 0.76 | |
| 31 | Apigenin O-(Hex-Ac) | 18.8 | 473.1093 | C23H22O11 | 268.0378 | 0.73 | ||
| 32 | Biochanin A-hexurunosyl-hexurunosyl | 19.5 | 637.1774 | C29H34O16 | 283.0618 | 0.65 | ||
| 33 | Apigenin O-(Hex-Ac) | 20.1 | 473.1095 | C23H22O11 | 268.0382 | 1.57 |
Contents of the main bioactive compounds identified in the Mix2 analyzed in negative-ionization mode
| No. | Compound | RT (min) | UV | Formula | MS2 main ion | MS2 fragments | mg/g DM | |
| 1 | 3-O-Caffeoylquinic acid | 4.7 | 215/325 | 353.0880 | C16H18O9 | 191.0553 | 179/161/135 | 6.91 |
| 2 | 2-O-Caffeoylhydroxycitric acid | 5.2 | 215/324 | 369.0464 | C15H14O11 | 189.003 | 127/207/179 | 0.78 |
| 3 | 1-O-Feruloylglucose | 5.7 | 215/324 | 355.1046 | C16H20O9 | 193.0498 | 149/0589/134 | 0.50 |
| 4 | Caffeic acid | 6.1 | 179.0342 | C9H8O4 | 135.0436 | 1.09 | ||
| 5 | Caffeoylmalic acid | 6.2 | 250/324 | 295.046 | C13H12O8 | 179.0336 | 133/207 | 1.27 |
| 6 | 2-O-Feruloylhydroxycitric acid | 8.2 | 215/324 | 383.0623 | C16H16O11 | 189.0039 | 191/337/127 | 3.64 |
| 7 | N-Malonyl-D-phenylalanine | 8.3 | 250.0723 | C12H13NO5 | 165.055 | 207 | 1.88 | |
| 8 | Astilbin | 9.2 | 449.1089 | C21H22O11 | 287.0561 | 259/243 | 1.07 | |
| 9 | Nigellicine | 9.4 | 245.0934 | C13H14N2O3 | 203.0829 | 0.69 | ||
| 10 | Quercetin O-Pen-Hex | 10.1 | 255/352 | 595.1298 | C26H28O16 | 300.0273 | 0.48 | |
| 11 | Isoquercitrin O-Dhex | 10.2 | 252/351 | 609.1459 | C27H30O16 | 300.0279 | 0.54 | |
| 12 | Quercetin O-Hex | 10.5 | 252/351 | 463.0874 | C21H20O12 | 301.0366 | 141/151 | 2.25 |
| 13 | Typhaneoside | 10.8 | 255/354 | 769.2207 | C34H42O20 | 314.0436 | 595 | 2.71 |
| 14 | Rutin | 11.0 | 255/352 | 609.1451 | C27H30O16 | 300.0275 | 5.73 | |
| 15 | 6-Hydroxykaempferol 7-glucoside isoquercitrin | 11.5 | 264/341 | 463.089 | C21H20O12 | 300.0284 | 1.64 | |
| 16 | Quercetin-O-glucuronide | 12.2 | 255/352 | 477.0681 | C21H18O13 | 301.0359 | 0.85 | |
| 17 | Kaempferol O-Hex | 12.3 | 265/343 | 447.0937 | C21H20O11 | 285.0407 | 1.0 | |
| 18 | Sorhamnetin 3-O-Dhex-Hex | 12.9 | 623.1631 | C28H33O16 | 314.0436 | 461/161 | 0.25 | |
| 19 | Patuletin O-Hex | 13.0 | 256/351 | 493.099 | C22H22O13 | 331.0469 | 447/285/151 | 0.41 |
| 20 | 3,5-Dicaffeoylquinic acid | 13.2 | 215/325 | 515.1208 | C25H24O12 | 353.0885 | 173/179/191 | 0.92 |
| 21 | Luteolin-O-Hex-Dhex | 13.9 | 265/343 | 593.1518 | C27H30O15 | 285.0409 | 1.43 | |
| 22 | Calendoflavoside | 14.1 | 351/000 | 623.1627 | C28H33O16 | 315.0515 | 269 | 0.71 |
| 23 | 3,4-Dicaffeoylquinic acid | 14.5 | 215/326 | 515.1208 | C25H24O12 | 353.0885 | 173/179/191 | 0.44 |
| 24 | Apigenin O-Hex | 14.7 | 266/339 | 431.0994 | C21H20O10 | 268.0382 | 2.82 | |
| 25 | Isorhamnetin-O-Hex | 14.9 | 267/338 | 447.0928 | C21H20O11 | 284.0332 | 300/0279/327/255 | 1.11 |
| 26 | 1,5-Dicaffeoylquinic acid | 15.2 | 214/325 | 515.1206 | C25H24O12 | 353.0885 | 173/179/191 | 6.18 |
| 27 | Isorhamnetin O-(Hex-Ac) | 15.3 | 260/000 | 519.1141 | C24H24O13 | 314.0436 | 331/299 | 1.75 |
| 28 | Quercetin O-(Hex-Ac) | 15.4 | 255/355 | 505.0963 | C23H22O13 | 300.0275 | 271 | 0.25 |
| 29 | 3-caffeoyl-4-dihydrocaffeoyl quinic acid | 15.9 | 215/325 | 517.1358 | C25H26O12 | 323.0779 | 193/161/179/149/221 | 0.49 |
| 30 | Apigenin O-(Hex-Ac) | 16.5 | 265/325 | 473.1101 | C23H22O11 | 268.0385 | 1.94 |
In vitro and in vivo anthelmintic activity against Haemonchus contortus
| Part A: In vitro | Concentration (μg/mL) | ||
| Egg hatch test ED50 ± SD | Methanolic extract | Aqueous extract | |
| Mix1 | 539.2 ± 174.4 | 940.0 ± 73.0** | |
| Mix2 | 486.9 ± 228.9 | 880.0 ± 67.8** | |
| Larval development test LD50 ± SD | |||
| Mix1 | 266.6 ± 107.2 | 922.7 ± 232.1** | |
| Mix2 | 826.4 ± 370.5 | 1256.5 ± 465.0** | |
| Part B: In vivo | Numbers of adult worms | ||
| Mean number of adult worms ± SD | Infected animals | Infected animals with Mix1 | Infected animals with Mix2 |
| 1523 ± 187 | 1113 ± 274* | 1327 ± 351 | |
In vitro activity: data are means ± SDs of three independent assays with duplicate samples. Ovicidal and larvicidal activities are expressed as the concentration (μg/mL) of a median lethal dose (ED50 and LD50, respectively; the concentration of a methanolic or aqueous extract that prevents 50% of the eggs from hatching or larvae from developing to the infective L3 stage) using the egg hatch test or larval development test
In vivo activity: *Reduction of adult worms relative to infected animals 70 days after infection (P < 0.05)
**Means within a row are significantly different at P < 0.01
Fig. 1Mean fecal egg counts for the groups of lambs infected with Haemonchus contortus
Inflammatory responses of the experimental lambs
| Parameter | Day | C | I | I + Mix1 | I + Mix2 | SD | Significance of effect | ||||
| Treatment | I vs. I + Mix1 | I vs. I + Mix2 | Time | Treatment × time | |||||||
| IgG | 22 | 0.073 | 0.321 | 0.544 | 0.525 | 0.0713 | ** | ** | * | NS | ** |
| (mg/mL) | 37 | 0.074 | 0.352 | 0.425 | 0.482 | 0.0858 | NS | NS | |||
| 51 | 0.115 | 0.506 | 0.314 | 0.418 | 0.0931 | ** | NS | ||||
| 70 | 0.091 | 0.484 | 0.244 | 0.351 | 0.0566 | ** | NS | ||||
| Calpro | 22 | 5.290 | 4.820 | 4.860 | 4.207 | 1.2650 | ** | NS | NS | ** | ** |
| (ng/mL) | 37 | 3.505 | 1.900 | 2.997 | 2.777 | 0.9263 | NS | NS | |||
| 51 | 5.050 | 4.178 | 4.642 | 1.833 | 0.9462 | NS | ** | ||||
| 70 | 3.665 | 4.877 | 5.882 | 2.178 | 1.3114 | NS | ** | ||||
C control uninfected animals, I infected animals, I + Mix1 infected animals with Mix1, I + Mix2 infected animals with Mix2, Calpro calprotectin, NS not significant
* P < 0.01, ** P < 0.001
Antioxidant status in the experimental lambs
| Parameter | Day | C | I | I + Mix1 | I + Mix2 | SD | Significance of effect | ||||
| Treatment | I vs. I + Mix1 | I vs. I + Mix2 | Time | Treatment × time | |||||||
| TAC | 22 | 0.552 | 0.537 | 0.538 | 0.543 | 0.055 | *** | NS | NS | NS | NS |
| (mmol/L) | 37 | 0.593 | 0.508 | 0.562 | 0.568 | 0.060 | NS | NS | |||
| 51 | 0.667 | 0.502 | 0.517 | 0.535 | 0.102 | NS | NS | ||||
| 70 | 0.560 | 0.458 | 0.550 | 0.548 | 0.075 | NS | NS | ||||
| SOD | 22 | 2020 | 3139 | 2705 | 3048 | 731.9 | *** | NS | NS | * | NS |
| (U/g Hb) | 37 | 2566 | 3572 | 3510 | 3768 | 1271 | NS | NS | |||
| 51 | 2288 | 3592 | 3510 | 4206 | 1002 | NS | NS | ||||
| 70 | 2865 | 3859 | 3895 | 3764 | 974.4 | NS | NS | ||||
| GPx | 22 | 0.114 | 0.109 | 0.108 | 0.101 | 0.038 | *** | NS | NS | *** | NS |
| (U/mL) | 37 | 0.101 | 0.052 | 0.064 | 0.055 | 0.030 | NS | NS | |||
| 51 | 0.091 | 0.075 | 0.051 | 0.053 | 0.022 | NS | NS | ||||
| 70 | 0.092 | 0.076 | 0.044 | 0.055 | 0.030 | NS | NS | ||||
TAC total antioxidant capacity of serum, SOD superoxide dismutase activity in erythrocytes, GPx glutathione peroxidase activity in serum, C control uninfected animals, I infected animals, I + Mix1 infected animals with Mix1, I + Mix2 infected animals with Mix2, NS not significant
* P < 0.05, *** P < 0.001
Mineral status in the sera of the experimental lambs
| Element | Day | C | I | I + Mix1 | I + Mix2 | SD | Significance of effect | ||||
| Treatment | I vs. I + Mix1 | I vs. I + Mix2 | Time | Treatment × time | |||||||
| Zn (mg/L) | 22 | 0.476 | 0.462 | 0.567 | 0.591 | 0.07 | * | NS | NS | *** | NS |
| 37 | 0.548 | 0.477 | 0.512 | 0.519 | 0.03 | NS | NS | ||||
| 51 | 0.590 | 0.512 | 0.542 | 0.582 | 0.04 | NS | NS | ||||
| 70 | 0.687 | 0.590 | 0.548 | 0.682 | 0.07 | NS | NS | ||||
| Fe (mg/L) | 22 | 1.317 | 0.510 | 1.089 | 0.789 | 0.35 | *** | * | NS | *** | * |
| 37 | 1.575 | 0.724 | 0.975 | 0.935 | 0.37 | NS | NS | ||||
| 51 | 2.120 | 0.998 | 1.180 | 1.536 | 0.49 | NS | NS | ||||
| 70 | 2.188 | 0.618 | 1.665 | 1.585 | 0.66 | *** | *** | ||||
| Cu (mg/L) | 22 | 0.774 | 0.651 | 0.834 | 0.841 | 0.09 | NS | ** | ** | *** | NS |
| 37 | 0.773 | 0.696 | 0.724 | 0.732 | 0.03 | NS | NS | ||||
| 51 | 0.817 | 0.730 | 0.810 | 0.795 | 0.04 | NS | NS | ||||
| 70 | 0.835 | 0.876 | 0.810 | 0.873 | 0.03 | NS | NS | ||||
C control uninfected animals, I infected animals, I + Mix1 infected animals with Mix1, I + Mix2 infected animals with Mix2, NS not significant
* P < 0.05, ** P < 0.01, *** P < 0.001
Fig. 2Unweighted pair group method with arithmetic mean algorithms (UPGMA) analysis of the DGGE profiles of the microbial communities from fecal samples of the lambs infected with Haemonchus contortus collected on days 0, 22, 37, 51 and 70 post-infection and treated with Mix1 and Mix 2